Biotech Showcase: Fueling Innovation: The Vital Role of Biotech in Alzheimer's Research

About this session

Panel followed by biotech showcase talks: (1) Phase 2a AD Trial Results: NTRX-07 Reduces Neuroinflammation and Inhibits Neurodegeneration Following 28-days of Treatment; (2) A Next-Generation circRNA Blood Biomarker Platform for Alzheimer's Disease Detection, Progression Prediction, and Clinical Deployment; (3) Sinaptica Therapeutics – Precuneus-directed TMS-EEG precision-neuromodulation platform.

Speakers

• LN

  Laura Nisenbaum

  Alzheimer's Drug Discovery Foundation (ADDF)

  Panelist

• MW

  Michael Weiner

  University of California, San Francisco (UCSF)

  Panelist

• DD

  David Dolby

  Dolby Family Ventures

  Panelist